通过-emodin 的雄性激素受体信号的对抗性
Jingqi Zhao1, Yantong Sun2, Li Ren1
1College of Food Science and Engineering, Jilin University, Changchun, 130062, China.
-埃莫丁通过阻断雄激素受体 (AR) 信号传递来抑制前列腺癌. 这种新型AR抗剂促进癌细胞死亡,并阻止AR进入细胞核,为癌症预防和治疗提供了潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 雄激素受体 (AR) 信号传递是前列腺癌发展和复发的关键因素.
- 准AR信号是前列腺癌治疗的主要策略.
研究的目的:
- 为了识别新型受体 (AR) 信号传导的对手.
- 调查-埃莫丁作为前列腺癌治疗的AR抗剂的潜力.
主要方法:
- 使用LNCaP细胞进行细胞生长抑制和细胞亡测定.
- 西方斑点和定量实时PCR分析AR蛋白水平和基因表达.
- 免疫光学来追踪AR的核转位.
- 分子对接和动力学模拟以研究-埃莫丁-AR相互作用.
主要成果:
- -埃莫丁通过诱导亡,显著抑制了LNCaP细胞生长.
- 阿洛伊-埃莫丁促进了AR蛋白体的降解,降低了AR蛋白水平.
- 阿洛伊-埃莫丁抑制了AR目标基因 (PSA,KLK2,TMPRSS2) 的转录.
- -埃莫丁通过与AR形成稳定的复合物来阻止AR的核转移,这可能会影响连接物结合.
结论:
- -埃莫丁作为一种新的AR抗剂,抑制AR信号通路,对前列腺癌至关重要.
- 阿洛伊-埃莫丁显示出作为前列腺癌预防或作为补充治疗的治疗剂的潜力.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
相关概念视频
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
Cell Signaling in Plants
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
